The 20 Best POEMS Syndrome Doctors Near Me in Wisconsin, US

Shamsuddin Virani is a Hematologist and an Oncologist practicing medicine in Burlington, Wisconsin. Dr. Virani is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 64 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Non-Hodgkin Lymphoma. Dr. Virani is board certified in American Board Of Internal Medicine, Hematology.

Malik Bandealy is a Hematologist and an Oncologist practicing medicine in Kenosha, Wisconsin. Dr. Bandealy is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 84 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Thrombocytopenia, and Adult Immune Thrombocytopenia. Dr. Bandealy is board certified in American Board Of Internal Medicine, Hematology.

Laura Mcgartland is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Mcgartland is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Mcgartland is board certified in American Board Of Internal Medicine, Medical Oncology.

Antony Ruggeri is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Ruggeri is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Adult Soft Tissue Sarcoma, and Urothelial Cancer. Dr. Ruggeri is board certified in American Board Of Internal Medicine, Medical Oncology.

Dr. Anita D’Souza is a professor of medicine (hematology/oncology). She completed her medical school from Goa Medical College, India where she graduated at the top of her class and was awarded Best Medical Graduate. She completed her internal medicine residency from William Beaumont Hospital in Michigan where she received the Zimmerman Award for Outstanding Clinical Judgment, Leadership, and Integrity. She completed her hematology/oncology fellowship from the Mayo Clinic in Rochester, Minnesota. She is a past recipient of the Daniel McCarty Award for Research Excellent and Women in Science Rising Pioneer Award at MCW. Dr. D'souza is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy. Dr. D'souza is board certified in Internal Medicine and Medical Oncology And Hematology. Dr. D'souza is currently accepting new patients.

Alissa Weber is a Hematologist and an Oncologist practicing medicine in Madison, Wisconsin. Dr. Weber is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Weber is board certified in American Board Of IM/Hematology , American Board Of IM/Medical Oncology , Drug Enforcement Administration , and Wisconsin Medical Examining Board.

Dr. O'Mahar is a board certified oncologist. She obtained her undergraduate degree from Stanford University and earned her medical degree from the Washington University School of Medicine in St. Louis. She completed her internship at Barnes-Jewish Hospital in St. Louis and her fellowship at the University of Wisconsin - Madison. Her area of expertise is the treatment of multiple myeloma, myelodysplastic syndromes, monoclonal gammopathy, melanoma and acute and chronic leukemia. In her free time, Dr. O'Mahar enjoys baking and writing sort stories and poetry. Dr. O'mahar is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 45 other conditions, according to our data. Her clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Myelodysplastic Syndrome (MDS), and Waldenstrom Macroglobulinemia. Dr. O'mahar is board certified in American Board Of IM/Hematology , American Board Of IM/Medical Oncology , American Board Of Internal Medicine , Drug Enforcement Administration , and Wisconsin Medical Examining Board.

Saurabh Rajguru is an Oncologist practicing medicine in Beaver Dam, Wisconsin. He has been practicing medicine for over 17 years. Dr. Rajguru is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Multiple Myeloma, and Bone Marrow Aspiration.

I can’t think of a job any more meaningful than one that allows you to be there to support people who have been diagnosed with cancer and help as they navigate such a difficult time in life. To me, a strong patientprovider relationship is so essential. It’s also incredibly important for patients to be active participants in their care and I encourage this by keeping them educated and updated with as much information as possible. The best way to approach the treatment process is by feeling confident about the plan. Dr. Schmidt is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, B-Cell Lymphoma, Angiosarcoma, and Bone Marrow Aspiration. Dr. Schmidt is board certified in Internal Medicine, American Board Of Internal Medicine (2012), American Board Of Internal Medicine (2016), and Medical Oncology, American Board Of Internal Medicine (2016).

Francis Cuevas is a Hematologist practicing medicine in Franklin, Wisconsin. Dr. Cuevas is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.

Giving hope to patients during one of the toughest phases of their lives is gratifying. I love establishing longterm relationships with patients, and I strive to provide the most uptodate, personalized treatments with compassion.My patients are partners in the decisions about their care. I ensure their values and goals matter most. Dr. Vallatharasu is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Multiple Myeloma, Paroxysmal Cold Hemoglobinuria, and Essential Thrombocythemia. Dr. Vallatharasu is board certified in Internal Medicine, American Board Of Internal Medicine (2016), American Board Of Internal Medicine (2019), and Medical Oncology, American Board Of Internal Medicine (2019).

Dr. Arbaje is a board certified oncologist. He obtained his medical degree from the Technologic Institute of Santo Domingo in the Dominican Republic. He completed his internship at Tulane University in New Orleans and served his fellowship at the University of Wisconsin - Madison. His area of expertise is the treatment of breast cancer. In his free time, Dr. Arbaje enjoys reading, cycling, running and swimming. Dr. Arbaje is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Multiple Myeloma, and Bone Marrow Aspiration. Dr. Arbaje is board certified in American Board Of IM/Medical Oncology , Drug Enforcement Administration , and Wisconsin Medical Examining Board.

Roy Kim is a Hematologist and an Oncologist practicing medicine in Madison, Wisconsin. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Thrombocytopenia, Autoimmune Hemolytic Anemia, Anemia, and Bone Marrow Aspiration. Dr. Kim is board certified in American Board Of IM/Hematology , Drug Enforcement Administration , and Wisconsin Medical Examining Board.

Adam Levin is a Hematologist and an Oncologist practicing medicine in Madison, Wisconsin. Dr. Levin is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL). Dr. Levin is board certified in American Board Of IM/Hematology , American Board Of IM/Medical Oncology , American Board Of Internal Medicine , Drug Enforcement Administration , and Wisconsin Medical Examining Board.

Priyanka Pophali is a Hematologist practicing medicine in Madison, Wisconsin. Dr. Pophali is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Ehab Atallah, MD, is a Professor of Medicine and Associate director of the cancer service line in the Medical College of Wisconsin Division of Hematology and Oncology, specializing in leukemia, myelodysplastic syndromes, myeloproliferative neoplasms and other bone marrow failure disorders at Froedtert Hospital. He graduated from Cairo University School of Medicine in 1994, then completed an internal medicine residency in the Cleveland Clinic Health System and a fellowship in hematology/oncology at the Karmanos Cancer Center in Detroit, Michigan, where he also served as Chief Fellow. He then went on to complete a leukemia fellowship at M.D. Anderson Cancer Center in Houston, Texas. Dr. Atallah is board certified/eligible in Internal Medicine, Medical Oncology, and Hematology. He has authorednumerous publications, including journal articles, meeting abstracts, and book chapters. His current research interests are treatment of patients with chronic myelogenous leukemia, chronic lymphocytic leukemia, acute lymphocytic leukemia, acute myelogenous leukemia, myeloproliferative neoplasms and myelodysplastic syndromes. He currently serves as the co-chair of the Eastern Cooperative Group (ECOG) leukemia committee. He is the administrative director of the H Jean Khoury Cure CML Consortium (HJKC3). The HJKC3 was established in 2016 and is a collaborative effort of physicians and researchers at 21 academic medical centers committed to CML research and improving patient care and quality of life. Dr. Atallah is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Atallah is board certified in Hematology and Internal Medicine. Dr. Atallah is currently accepting new patients.

Nirav Shah, MD, MSHP, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in lymphoma, CAR-T cell therapy, and stem cell transplant at Froedtert Hospital. He graduated with honors and Alpha Omega Alpha Honor Society membership from the University of Illinois at Chicago College of Medicine in 2008. He then completed his internal medicine residency at Massachusetts General Hospital in Boston, Massachusetts in 2011. Post-residency, he took a position at Northwestern Memorial Hospital in Hospitalist medicine before proceeding to the University of Pennsylvania where he completed both hematology/oncology fellowship and a Master’s degree in Health Policy research in 2015. His research focus is in the area of novel agents and cell therapy development for hematological malignancies. He is currently director of the Bone Marrow Transplant and Cellular Therapy Program at the Medical College of Wisconsin. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Marginal Zone Lymphoma (MZL), Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Shah is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Shah is currently accepting new patients.

Dr. Hamadani is a Professor of Medicine and Chief of Hematologic Malignancies at the Medical College of Wisconsin (MCW) in Milwaukee, WI. He serves as the Associate Director of Clinical Research at the MCW Clinical Cancer Center and holds the Cancer Center Scholar Endowed Chair. Dr. Hamadani graduated with honors from King Edward Medical College (Pakistan), in 2001. He completed internal medicine residency from the University of Oklahoma followed by a fellowship in Hematology/Oncology at The Ohio State University. He is considered an international key opinion leader in the fields of hematopoietic cell transplantation, cellular therapy and lymphoid malignancies. He has authored over 450 peer-reviewed publications. As the Principal Protocol Officer for BMT CTN and Co-PI of MCW LAPS Grant he has extensive experience in clinical trial design and has been involved in the development and execution of several practice changing transplant clinical trials. He chairs the ASTCT Committee on Practice Guidelines and served as the Secretary of American Society for Transplant and Cellular Therapies (2024-26). His key areas of search include graft-versus-host disease (GvHD), developmental therapeutics for lymphoid malignancies and hematopoietic cell transplantation. His clinical expertise includes lymphomas, transplant, and CAR-T cell therapies. He considers mentoring junior faculty and trainees as his top-most priority. Dr. Hamadani is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hamadani is board certified in Internal Medicine, Hematology, and Medical Oncology. Dr. Hamadani is currently accepting new patients.

Binod Dhakal, MD, MS, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in multiple myeloma and plasma cell disorders. He graduated from Manipal College of Medical Sciences, Pokhara Nepal in 2004, completed internal medicine residency at Saint Francis Hospital, Evanston, IL, and a fellowship in hematology/oncology at the Medical College of Wisconsin, where he also served as a chief fellow. Prior to joining the fellowship, he was an assistant professor of medicine (general internal medicine) at the Medical College in Wisconsin. He has authored numerous publications, including journal articles, meeting abstracts and book chapters. He has also won several awards during his fellowship which include the American Society of Clinical Oncology (ASCO) Merit Award; Medical College of Wisconsin Affiliated Hospitals (MCWAH) research award; Central Society for Clinical and Translational Research (CSCTR) best oral abstract and travel trainee award; American Society for Blood and Marrow Transplantation (ASBMT) clinical research training course; and, Outstanding Medical School Teacher award. Additionally, he was the recipient of the Mazie Froedtert Willms and Sue Froedtert Cancer Scholarship, and obtained his Master’s Degree in Clinical and Translational Science. His current research interests focus on novel drug treatments for patients with multiple myeloma and related plasma cell disorders by designing and conducting early phase clinical trials. Dr. Dhakal is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dhakal is currently accepting new patients.

Dr. Foy is an Associate Professor of Medicine at the Medical College of Wisconsin (MCW) in the Division of Hematology and Oncology. He specializes in the treatment of classical hematologic conditions, with expertise in evaluation of abnormal blood counts, bleeding disorders, blood clotting and vascular anomalies. His research focuses on management of hereditary hemorrhagic telangiectasia (HHT) and medical education.A native of Milwaukee, he graduated from the Stritch School of Medicine at Loyola University in Chicago in 2004. He then completed an internal medicine residency and Hematology-Oncology fellowship at the University of Minnesota in Minneapolis. He is a distinguished educator who has won multiple teaching awards while at MCW. Dr. Foy is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Hereditary Hemorrhagic Telangiectasia, MAGIC Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Bone Marrow Aspiration. Dr. Foy is board certified in Internal Medicine and Hematology. Dr. Foy is currently accepting new patients.